A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

NCT02928406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1004

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Cancer

Interventions

DRUG: Atezolizumab

Sponsor

Hoffmann-La Roche